Delivery Order SPE2DB22D1202-SPE2DB25FUSN7

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TABLET 60S. The contract is a firm fixed price arrangement with a ceiling value of $26,258.45 and a period of performance through July 24, 2024. The contract is not set aside for any special program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,563.93 firm fixed-price delivery order covers the supply of OTEZLA 30 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of OTEZLA 30 MG TABLET 60S. The contract has a firm fixed price of $16,830.71 and a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award is a delivery order valued at $35,643.37 made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a period of performance through November 21, 2023. The contract is a firm fixed price arrangement and was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $22,243.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of January 22, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTEZLA 30 MG TABLET 60S. The delivery order, valued at $8,538.08, has a firm fixed price and a period of performance through September 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $15,397.10 and is a firm fixed price delivery order contract with an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,616.87 firm-fixed-price delivery order contract is for the supply of OTEZLA 30 mg tablets. The contract has an ultimate completion date of November 5, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,821.76 Firm Fixed Price Delivery Order contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a performance period ending on February 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,533.22 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSN7
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a delivery order with a ceiling value of $16,318.40 for the supply of OTEZLA 30 MG TABLET 60S. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance running through February 12, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/13/25, 10:02 AM